IN8bio Inc INAB Q1 2026 Earnings EPS Surprise of 63 Highlights Cost Discipline in PreRevenue Biotech MGM Q1 2026 Earnings EPS Misses Estimates Amidst Operational Pressures HCA Q1 2026 Earnings EPS Misses Estimates Amid Narrow Surprise and Flat Stock Reaction Versus Systems Inc Q4 2025 Earnings Continued Losses Amid Restructuring Efforts CVKD Q1 2026 Earnings Narrower Loss Surprises Clinical Progress Maintained BMNR Q1 2026 Earnings Positive EPS Surprise Amid No Revenue Disclosure